Page last updated: 2024-08-24

antineoplaston a10 and Neuroectodermal Tumors, Primitive

antineoplaston a10 has been researched along with Neuroectodermal Tumors, Primitive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burzynski, SR; Dolgopolov, V; Janicki, T; Jurida, G; Khan, M; Szymkowski, B; Weaver, RA	1

Trials

1 trial(s) available for antineoplaston a10 and Neuroectodermal Tumors, Primitive

Article	Year
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1. Integrative cancer therapies, 2005, Volume: 4, Issue:2 Topics: Antineoplastic Agents; Benzeneacetamides; Brain Neoplasms; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glutamine; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome	2005

Article

Year

Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.

Integrative cancer therapies, 2005, Volume: 4, Issue:2

Topics: Antineoplastic Agents; Benzeneacetamides; Brain Neoplasms; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glutamine; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome

2005